HBW Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Monograph OTCs Subject To Adverse Event Reporting Under Hatch Bill

This article was originally published in The Rose Sheet

Executive Summary

Firms that make, pack or distribute over-the-counter drugs approved under monographs will have to be in compliance with a new adverse event reporting law by December 2007 if President George W. Bush signs a recently passed bill
Advertisement

Related Content

Expert Gives Lowdown On Adverse Event Reporting Bill For Monograph OTCs
Expert Gives Lowdown On Adverse Event Reporting Bill For Monograph OTCs
Advertisement
UsernamePublicRestriction

Register

RS014419

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel